BSI-302

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBSI-302
Drug Alias NameBSI-300 seriesiodothyronine series (BiPar Sciences)anti-tubulin series (BiPar Sciences)BSI-302BSI-301
ClassificationSmall molecules
Mechanisms of ActionTubulin inhibitorsAngiogenesis inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiPar Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiPar Sciences Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A